BioGenes Hopes Role in EU-Funded Alzheimer's Biomarker Project Will Raise Profile in US

BioGenes will supply antibodies for the project, called cNeupro. The deal will enable it to share ownership of the antibodies and pocket royalties on the ones that lead to commercial products.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.